Abstract
The clinical effectiveness movement underpins a major health professional culture change which is occurring worldwide. Clinical practice guidelines are an important component of this movement and seek to promote evidence-based care, and combine quality and efficiency with equity of access in a patient centred approach. However some areas of practice are more amenable to guidelines than others and may thus be advantaged in terms of resource allocation. While high grade evidence from randomised controlled trials forms the basis for many cardiovascular guidelines, selection bias may considerably limit the generalisability of such data. This is particularly exemplified by clinical trials in heart failure which are not necessarily relevant to the majority of older patients with heart failure in the community. Future research in heart failure should be oriented towards the community and realigned in the context of health care priorities for the more elderly who have yet to benefit from previous advances.
References
SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293–302.
Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525–533.
CIBIS II Investigators. The cardiac insufficiency bisoprolol study: A randomised trial. Lancet 1999;353:9–13.
The MERIT HF Study Group. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Mortality results. Lancet 1999;353:2001–2007.
Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective. J Am Coll Cardiol 1995;26:1565–1574.
Konstam MA, Dracup K, Baker DW, et al. Heart failure: Ejection fraction and care of patients with left ventricular systolic dysfunction. Agency for Health Care Policy and Research Clinical Practice Guideline No. 11. ACHPR publication no. 94-0612, US Department of Health and Human Services, Rockville MD. June 1994.
TheTask Force of theWorking Group on Heart Failure of the European Society of Cardiology. Guidelines: The treatment of heart failure. Eur Heart J 1997;18:736–753.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharpe, N. Clinical Trials and the Real World: Selection Bias and Generalisability of Trial Results. Cardiovasc Drugs Ther 16, 75–77 (2002). https://doi.org/10.1023/A:1015327801114
Issue Date:
DOI: https://doi.org/10.1023/A:1015327801114